Skye Bioscience, Inc. · NASDAQ:SKYE

Andrew J. Schwab reported a 30.20% stake in Skye Bioscience, Inc. (Schedule 13D/A)

Event Aug 14, 2026 · Filed Aug 18, 2026

Andrew J. Schwab reported a 30.20% stake in Skye Bioscience, Inc., 11,273,407 shares, with active intent on Aug 14, 2026. Filed Aug 18, 2026 (Schedule 13D/A).

Stake
30.20%
Shares
11,273,407
Intent
Active
What changed
Stake changed
Filed together
9 holders

The filing in full

HolderStakeShares
5AM Partners VII, LLC25.90%9,619,519
5AM Ventures VII, L.P.25.90%9,619,519
5AM Partners II, LLC4.10%1,467,637
5AM Ventures II, L.P.4.00%1,411,974
5AM Co-Investors II, L.P.0.20%55,663
Andrew J. Schwab30.20%11,273,407
Kush Parmar25.90%9,619,519
John D. Diekman4.10%1,467,637
Scott M. Rocklage4.10%1,467,637

Source

View original at SEC

Related